The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Mar. 10, 2015
Filed:
Jan. 20, 2012
Lih-geeng Chen, Kaohsiung, TW;
Yen-hsu Chen, Kaohsiung, TW;
Chin Hsu, Kaohsiung, TW;
Hsin-ju Chien, Kaohsiung, TW;
Shih-han Kao, Kaohsiung, TW;
Yu-wei Chang, Kaohsiung, TW;
Wan-chun Huang, Kaohsiung, TW;
Lih-Geeng Chen, Kaohsiung, TW;
Yen-Hsu Chen, Kaohsiung, TW;
Chin Hsu, Kaohsiung, TW;
Hsin-Ju Chien, Kaohsiung, TW;
Shih-Han Kao, Kaohsiung, TW;
Yu-Wei Chang, Kaohsiung, TW;
Wan-Chun Huang, Kaohsiung, TW;
Kaohsiung Medical University, Kaohsiung, TW;
Abstract
A method of inhibiting the growth of Gram-positive bacteria comprising administering an effective amount of Tellimagrandin II, its pharmaceutically acceptable salt, enantiomer, isomer or tautomer to a subject is provided. The Gram-positive bacteria comprise methicillin-resistant. A method of treating sepsis comprising administering an effective amount of Tellimagrandin II, its pharmaceutically acceptable salt, enantiomer, isomer or tautomer to a subject is also provided. A method of treating leukemia comprising administering an effective amount of Tellimagrandin II, its pharmaceutically acceptable salt, enantiomer, isomer or tautomer to a subject is further provided.